178 related articles for article (PubMed ID: 4973304)
1. Protection against Pseudomonas aeruginosa infection by immunisation with fractions of culture filtrates of Ps. aeruginosa.
Jones RJ
Br J Exp Pathol; 1968 Oct; 49(5):411-20. PubMed ID: 4973304
[No Abstract] [Full Text] [Related]
2. Protective properties and haemagglutinins in serum from humans and in serum from mice injected with a new polyvalent Pseudomonas vaccine.
Jones RJ; Roe EA
Br J Exp Pathol; 1975 Feb; 56(1):34-43. PubMed ID: 812544
[TBL] [Abstract][Full Text] [Related]
3. Specificity of the protective response induced by the slime layer of Pseudomonas aeruginosa.
Mates A; Zand P
J Hyg (Lond); 1974 Aug; 73(1):75-84. PubMed ID: 4213979
[TBL] [Abstract][Full Text] [Related]
4. Passive immunisation against Gram-negative bacilli in burns.
Jones RJ
Br J Exp Pathol; 1970 Feb; 51(1):53-8. PubMed ID: 4985031
[TBL] [Abstract][Full Text] [Related]
5. Experimental immunization with attenuated mutants of Pseudomonas aeruginosa.
Syeklocha D
Can J Microbiol; 1973 May; 19(5):573-80. PubMed ID: 4196781
[No Abstract] [Full Text] [Related]
6. Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis.
Faezi S; Sattari M; Mahdavi M; Roudkenar MH
Burns; 2011 Aug; 37(5):865-72. PubMed ID: 21334822
[TBL] [Abstract][Full Text] [Related]
7. Serologic and protective cross-reactivity of antisera to Pseudomonas aeruginosa extracellular slime glycolipoprotein.
Yushkova NA; Kholodkova EV; Korobova TS; Stanislavsky ES
Acta Microbiol Hung; 1986; 33(2):147-56. PubMed ID: 3101393
[TBL] [Abstract][Full Text] [Related]
8. Common protective antigen (OEP) of Pseudomonas aeruginosa.
Abe C; Shionoya H; Hirao Y; Okada K; Homma JY
Jpn J Exp Med; 1975 Oct; 45(5):355-9. PubMed ID: 817054
[TBL] [Abstract][Full Text] [Related]
9. Protective activity of immune sera against extracellular slime from Pseudomonas aeruginosa on experimental infection in mice.
Sokalska M; Maresz-Babczyszyn J
Arch Immunol Ther Exp (Warsz); 1981; 29(5):643-52. PubMed ID: 6812542
[TBL] [Abstract][Full Text] [Related]
10. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
[TBL] [Abstract][Full Text] [Related]
11. Biological and immunochemical properties of culture filtrates of virulent and avirulent strains of Pseudomonas aeruginosa.
Carney SA; Jones RJ
Br J Exp Pathol; 1968 Oct; 49(5):395-410. PubMed ID: 4973303
[No Abstract] [Full Text] [Related]
12. Passive protection of mice against Pseudomonas aeruginosa by serum from recently vaccinated mice.
Jones RJ; Lilly HA; Lowbury EJ
Br J Exp Pathol; 1971 Jun; 52(3):264-70. PubMed ID: 4996963
[TBL] [Abstract][Full Text] [Related]
13. Comparative studies on the protective potential of antisera directed against four antigenic preparations from Pseudomonas aeruginosa.
Johnston LJ; Syeklocha D
Can J Microbiol; 1972 Oct; 18(10):1607-11. PubMed ID: 4628185
[No Abstract] [Full Text] [Related]
14. OprF/I-vaccinated sera inhibit binding of human interferon-gamma to Pseudomonas aeruginosa.
Ding B; von Specht BU; Li Y
Vaccine; 2010 Jun; 28(25):4119-22. PubMed ID: 20433804
[TBL] [Abstract][Full Text] [Related]
15. The slime of Pseudomonas aeruginosa: biological characterization and possible role in experimental infection.
Sensakovic JW; Bartell PF
J Infect Dis; 1974 Feb; 129(2):101-9. PubMed ID: 4204237
[No Abstract] [Full Text] [Related]
16. Induction in mice of cell-mediated immunity to Pseudomonas aeruginosa by high molecular weight polysaccharide and vinblastine.
Pier GB; Markham RB
J Immunol; 1982 May; 128(5):2121-5. PubMed ID: 6174622
[TBL] [Abstract][Full Text] [Related]
17. The epidemiology of Pseudomonas aeruginosa and the development of a polyvalent vaccine.
Pranter W; Staerk J; Zellner R; Zwisler O
Prog Immunobiol Stand; 1971; 5():414-8. PubMed ID: 4633968
[No Abstract] [Full Text] [Related]
18. [Inhibition of generalization of wound infection in immunized rats].
Pal'tsyn AA; Grishina IA; Kolokol'chikova EG; Chervonskaia NV; Badikova AK; Popova EP
Biull Eksp Biol Med; 1994 May; 117(5):545-6. PubMed ID: 9296716
[No Abstract] [Full Text] [Related]
19. Type-specific immunity in pseudomonas diseases.
Crowder JG; Fisher MW; White A
J Lab Clin Med; 1972 Jan; 79(1):47-54. PubMed ID: 4621414
[No Abstract] [Full Text] [Related]
20. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
